Adjunct Professor of Regulatory Compliance
School of Pharmacy and Health Sciences
- Regulatory Compliance
- PharmD, Fairleigh Dickinson University School of Pharmacy
- MBA, FDU Silberman School of Business
- BS, University of the Sciences in Philadelphia
Dr. Hanna Desai joined Fairleigh Dickinson University School of Pharmacy and Health Sciences as an Adjunct Professor in August 2021. Dr. Desai received her B.S. in Pharmaceutical Sciences from the University of the Sciences in 2013. She completed the PharmD/MBA dual degree program at FDU from August 2013- May 2017. Dr. Desai is a licensed pharmacist in the state of NJ.
In 2017, Dr. Desai began her regulatory career at Teva Pharmaceuticals. In 2018, she pursued regulatory affairs and clinical development in oncology/hematology at Janssen Pharmaceuticals, a company of Johnson and Johnson. By the end of 2022, Dr. Desai joined Bristol Myers Squibb to support the regulatory/clinical development of novel oncology compounds. Over the years, Dr. Desai has supported oncology drug development in adult and pediatric groups, novel mechanisms of action, and rare diseases. Her passions include diversity in clinical trials, improving patient access to treatments/affordable care, and pioneering several leadership initiatives.
The goal of the regulatory compliance course is to bridge the knowledge gap for students seeking to understand different roles in the pharmaceutical industry, with a strong emphasis on drug development within a global regulatory framework.
Important Note: Faculty profiles may include links to one or more non-FDU websites, including websites self-maintained by faculty to provide additional information about their publications, scholarly pursuits, and other information of interest. If you click on these links, you will be leaving the FDU-maintained website and will be directed to a site that is not under the control of FDU. FDU is not responsible for the content or accessibility of linked non-FDU websites. If, however, you experience a problem with the content or accessibility of a linked website, please contact us using the information on our Accessibility page.